Skip to content
PubMed This is a summary of 98 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 98 referenced papers

Top Authors

Ralf Baron
University Hospital Schleswig-Holstein
Rolf‐Detlef Treede
Heidelberg University
Andrew S.C. Rice
Imperial College London
Sheena Derry
University of Oxford
Andrew Moore
University of Oxford
Rayaz A. Malik
Weill Cornell Medical College in Qatar
Philip J Wiffen
Thame Community Hospital
Nurcan Üçeyler
Universitätsklinikum Würzburg
Simon Haroutounian
Washington University in St. Louis
Thomas R. Tölle
TUM Klinikum

Top Institutions

Ranked by publications Top 10 institutions
10

Rutgers, The State University of New Jersey

New Brunswick, United States

16 papers

References

References (98)
  1. 1

    [Postherpetic neuralgia].

    Goßrau G

    Der Nervenarzt 2015; (86(2)):219-28; quiz 229-30 doi:10.1007/s00115-014-4233-1.

    PMID: 25659844
  2. 2

    Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats.

    Kanao M, Kanda H, Huang W, et al.

    Anesthesia and analgesia 2015; (120(6)):1394-404 doi:10.1213/ANE.0000000000000729.

    PMID: 25851180
  3. 3

    Neuronal changes induced by Varicella Zoster Virus in a rat model of postherpetic neuralgia.

    Guedon JM, Yee MB, Zhang M, et al.

    Virology 2015; (482()):167-80.

    PMID: 25880108
  4. 4

    Inflammation in the pathogenesis of lyme neuroborreliosis.

    Ramesh G, Didier PJ, England JD, et al.

    The American journal of pathology 2015; (185(5)):1344-60.

    PMID: 25892509
  5. 5

    5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability.

    Navez ML, Monella C, Bösl I, et al.

    Pain and therapy 2015; (4(1)):1-15 doi:10.1007/s40122-015-0034-x.

    PMID: 25896574
  6. 6

    Posttreatment Lyme disease syndrome.

    Aucott JN

    Infectious disease clinics of North America 2015; (29(2)):309-23.

    PMID: 25999226
  7. 7

    Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo.

    Zerboni L, Arvin A

    PLoS pathogens 2015; (11(6)):e1004989 doi:10.1371/journal.ppat.1004989.

    PMID: 26090802
  8. 8

    A systematic review and meta-analysis of risk factors for postherpetic neuralgia.

    Forbes HJ, Thomas SL, Smeeth L, et al.

    Pain 2016; (157(1)):30-54 doi:10.1097/j.pain.0000000000000307.

    PMID: 26218719
  9. 9

    Epidermal innervation morphometry by immunofluorescence and bright-field microscopy.

    Nolano M, Biasiotta A, Lombardi R, et al.

    Journal of the peripheral nervous system : JPNS 2015; (20(4)):387-91 doi:10.1111/jns.12146.

    PMID: 26309146
  10. 10

    Causes of neuropathy in patients referred as "idiopathic neuropathy".

    Farhad K, Traub R, Ruzhansky KM, Brannagan TH

    Muscle & nerve 2016; (53(6)):856-61 doi:10.1002/mus.24969.

    PMID: 26561790
  11. 11

    Distal Symmetric Polyneuropathy: A Review.

    Callaghan BC, Price RS, Feldman EL

    JAMA 2015; (314(20)):2172-81 doi:10.1001/jama.2015.13611.

    PMID: 26599185
  12. 12

    Post-herpetic Neuralgia: a Review.

    Hadley GR, Gayle JA, Ripoll J, et al.

    Current pain and headache reports 2016; (20(3)):17 doi:10.1007/s11916-016-0548-x.

    PMID: 26879875
  13. 13

    The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence.

    de León-Casasola OA, Mayoral V

    Journal of pain research 2016; (9()):67-79 doi:10.2147/JPR.S99231.

    PMID: 26929664
  14. 14

    Varicella zoster virus infection.

    Gershon AA, Breuer J, Cohen JI, et al.

    Nature reviews. Disease primers 2015; (1()):15016 doi:10.1038/nrdp.2015.16.

    PMID: 27188665
  15. 15

    Pinprick Testing in Small Fiber Neuropathy: Accuracy and Pitfalls.

    Blackmore D, Siddiqi ZA

    Journal of clinical neuromuscular disease 2016; (17(4)):181-6 doi:10.1097/CND.0000000000000116.

    PMID: 27224431
  16. 16

    The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses.

    Shackleton T, Ram S, Black M, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2016; (122(1)):61-71.

    PMID: 27260275
  17. 17

    Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study.

    Forbes HJ, Bhaskaran K, Thomas SL, et al.

    Neurology 2016; (87(1)):94-102 doi:10.1212/WNL.0000000000002808.

    PMID: 27287218
  18. 18

    Profile of the capsaicin 8% patch for the management of neuropathic pain associated with postherpetic neuralgia: safety, efficacy, and patient acceptability.

    Laklouk M, Baranidharan G

    Patient preference and adherence 2016; (10()):1913-1918 doi:10.2147/PPA.S76506.

    PMID: 27703336
  19. 19

    Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.

    Mallick-Searle T, Snodgrass B, Brant JM

    Journal of multidisciplinary healthcare 2016; (9()):447-454 doi:10.2147/JMDH.S106340.

    PMID: 27703368
  20. 20

    Diagnostic value of blood tests for occult causes of initially idiopathic small-fiber polyneuropathy.

    Lang M, Treister R, Oaklander AL

    Journal of neurology 2016; (263(12)):2515-2527 doi:10.1007/s00415-016-8270-5.

    PMID: 27730378
  21. 21

    Intraepidermal Nerve Fiber Density: Diagnostic and Therapeutic Relevance in the Management of Chronic Pruritus: a Review.

    Pereira MP, Mühl S, Pogatzki-Zahn EM, et al.

    Dermatology and therapy 2016; (6(4)):509-517 doi:10.1007/s13555-016-0146-1.

    PMID: 27730494
  22. 22

    Neuroborreliosis.

    Halperin JJ

    Journal of neurology 2017; (264(6)):1292-1297 doi:10.1007/s00415-016-8346-2.

    PMID: 27885483
  23. 23

    Characterization of Prostacyclin-associated Leg Pain in Patients with Pulmonary Arterial Hypertension.

    Pagani-Estévez GL, Swetz KM, McGoon MD, et al.

    Annals of the American Thoracic Society 2017; (14(2)):206-212 doi:10.1513/AnnalsATS.201609-674OC.

    PMID: 27898216
  24. 24

    Gasserian Ganglion and Retrobulbar Nerve Block in the Treatment of Ophthalmic Postherpetic Neuralgia: A Case Report.

    Huang J, Ni Z, Finch P

    Pain practice : the official journal of World Institute of Pain 2017; (17(7)):961-967 doi:10.1111/papr.12547.

    PMID: 27996187
  25. 25

    Topical capsaicin (high concentration) for chronic neuropathic pain in adults.

    Derry S, Rice AS, Cole P, et al.

    The Cochrane database of systematic reviews 2017; (1()):CD007393 doi:10.1002/14651858.CD007393.pub4.

    PMID: 28085183
  26. 26

    Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations.

    Vollert J, Maier C, Attal N, et al.

    Pain 2017; (158(8)):1446-1455 doi:10.1097/j.pain.0000000000000935.

    PMID: 28595241
  27. 27

    Gabapentin for chronic neuropathic pain in adults.

    Wiffen PJ, Derry S, Bell RF, et al.

    The Cochrane database of systematic reviews 2017; (6()):CD007938 doi:10.1002/14651858.CD007938.pub4.

    PMID: 28597471
  28. 28

    Local Brain Activity Differences Between Herpes Zoster and Postherpetic Neuralgia Patients: A Resting-State Functional MRI Study.

    Cao S, Li Y, Deng W, et al.

    Pain physician 2017; (20(5)):E687-E699.

    PMID: 28727713
  29. 29

    Guillain-Barré Syndrome.

    Donofrio PD

    Continuum (Minneapolis, Minn.) 2017; (23(5, Peripheral Nerve and Motor Neuron Disorders)):1295-1309 doi:10.1212/CON.0000000000000513.

    PMID: 28968363
  30. 30

    Quantitative and qualitative normative dataset for intraepidermal nerve fibers using skin biopsy.

    Collongues N, Samama B, Schmidt-Mutter C, et al.

    PloS one 2018; (13(1)):e0191614 doi:10.1371/journal.pone.0191614.

    PMID: 29370274
  31. 31

    Sensory symptom profiles differ between trigeminal and thoracolumbar postherpetic neuralgia.

    Rehm S, Groβkopf M, Kabelitz M, et al.

    Pain reports 2018; (3(1)):e636 doi:10.1097/PR9.0000000000000636.

    PMID: 29430564
  32. 32

    Herpes Zoster and Postherpetic Neuralgia: Prevention and Management.

    Saguil A, Kane S, Mercado M, Lauters R

    American family physician 2017; (96(10)):656-663.

    PMID: 29431387
  33. 33

    Gabapentin for Chronic Neuropathic Pain.

    Moore A, Derry S, Wiffen P

    JAMA 2018; (319(8)):818-819 doi:10.1001/jama.2017.21547.

    PMID: 29486015
  34. 34

    Title not available

    Sommer C, Üçeyler N

    Fortschritte der Neurologie-Psychiatrie 2018; (86(8)):509-518 doi:10.1055/a-0648-0450.

    PMID: 30125923
  35. 35

    Structural, functional, and symptom relations in painful distal symmetric polyneuropathies: a systematic review.

    Karlsson P, Hincker AM, Jensen TS, et al.

    Pain 2019; (160(2)):286-297 doi:10.1097/j.pain.0000000000001381.

    PMID: 30157133
  36. 36

    Office approach to small fiber neuropathy.

    Tavee JO

    Cleveland Clinic journal of medicine 2018; (85(10)):801-812 doi:10.3949/ccjm.85a.17124.

    PMID: 30289758
  37. 37

    Modalities in managing postherpetic neuralgia.

    Shrestha M, Chen A

    The Korean journal of pain 2018; (31(4)):235-243 doi:10.3344/kjp.2018.31.4.235.

    PMID: 30310548
  38. 38

    AAPT Diagnostic Criteria for Peripheral Neuropathic Pain: Focal and Segmental Disorders.

    Freeman R, Edwards R, Baron R, et al.

    The journal of pain 2019; (20(4)):369-393 doi:10.1016/j.jpain.2018.10.002.

    PMID: 30527971
  39. 39

    Somatosensory profiles in acute herpes zoster and predictors of postherpetic neuralgia.

    Kramer S, Baeumler P, Geber C, et al.

    Pain 2019; (160(4)):882-894 doi:10.1097/j.pain.0000000000001467.

    PMID: 30585985
  40. 40

    The IASP classification of chronic pain for ICD-11: chronic neuropathic pain.

    Scholz J, Finnerup NB, Attal N, et al.

    Pain 2019; (160(1)):53-59 doi:10.1097/j.pain.0000000000001365.

    PMID: 30586071
  41. 41

    Pregabalin for neuropathic pain in adults.

    Derry S, Bell RF, Straube S, et al.

    The Cochrane database of systematic reviews 2019; (1()):CD007076 doi:10.1002/14651858.CD007076.pub3.

    PMID: 30673120
  42. 42

    Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: the ectopic pacemaker hypothesis.

    Devor M

    Pain reports 2018; (3(6)):e702 doi:10.1097/PR9.0000000000000702.

    PMID: 30706041
  43. 43

    The Effect of Interventional Pain Management on Treating Postherpetic Neuralgia.

    Guo S, Shen M, Zhang L, et al.

    Indian journal of dermatology 2019; (64(3)):251 doi:10.4103/ijd.IJD_130_18.

    PMID: 31148876
  44. 44

    Interventional Treatments for Postherpetic Neuralgia: A Systematic Review.

    Lin CS, Lin YC, Lao HC, Chen CC

    Pain physician 2019; (22(3)):209-228.

    PMID: 31151330
  45. 45

    High-Voltage, Long-Duration Pulsed Radiofrequency on Gasserian Ganglion Improves Acute/Subacute Zoster-Related Trigeminal Neuralgia: A Randomized, Double-Blinded, Controlled Trial.

    Wan C, Dong DS, Song T

    Pain physician 2019; (22(4)):361-368.

    PMID: 31337167
  46. 46

    Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia.

    Gudin J, Fudin J, Wang E, et al.

    Journal of managed care & specialty pharmacy 2019; (25(12)):1387-1396 doi:10.18553/jmcp.2019.19093.

    PMID: 31589557
  47. 47

    Clinical Features Indicating the Need for Mechanical Ventilation in Patients with Guillain Barre Syndrome.

    Umer SR, Nisa Q, Kumari M, et al.

    Cureus 2019; (11(8)):e5520 doi:10.7759/cureus.5520.

    PMID: 31687295
  48. 48

    Therapeutic Approaches for Peripheral and Central Neuropathic Pain.

    Szok D, Tajti J, Nyári A, Vécsei L

    Behavioural neurology 2019; (2019()):8685954 doi:10.1155/2019/8685954.

    PMID: 31871494
  49. 49

    Utility of lidocaine as a topical analgesic and improvements in patch delivery systems.

    Gudin J, Nalamachu S

    Postgraduate medicine 2020; (132(1)):28-36 doi:10.1080/00325481.2019.1702296.

    PMID: 31900074
  50. 50

    COVID-19: A Global Threat to the Nervous System.

    Koralnik IJ, Tyler KL

    Annals of neurology 2020; (88(1)):1-11 doi:10.1002/ana.25807.

    PMID: 32506549
  51. 51

    COVID-19-associated coagulopathy: An exploration of mechanisms.

    Colling ME, Kanthi Y

    Vascular medicine (London, England) 2020; (25(5)):471-478 doi:10.1177/1358863X20932640.

    PMID: 32558620
  52. 52

    Deficits in ascending and descending pain modulation pathways in patients with postherpetic neuralgia.

    Li H, Li X, Feng Y, et al.

    NeuroImage 2020; (221()):117186 doi:10.1016/j.neuroimage.2020.117186.

    PMID: 32711060
  53. 53

    Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria.

    Freeman R, Gewandter JS, Faber CG, et al.

    Neurology 2020; (95(22)):1005-1014 doi:10.1212/WNL.0000000000010988.

    PMID: 33055271
  54. 54

    Mechanical ventilation in Guillain-Barré syndrome.

    Shang P, Zhu M, Baker M, et al.

    Expert review of clinical immunology 2020; (16(11)):1053-1064 doi:10.1080/1744666X.2021.1840355.

    PMID: 33112177
  55. 55

    Contribution of Skin Biopsy in Peripheral Neuropathies.

    Nolano M, Tozza S, Caporaso G, Provitera V

    Brain sciences 2020; (10(12)) doi:10.3390/brainsci10120989.

    PMID: 33333929
  56. 56

    Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain.

    McFarland AJ, Yousuf MS, Shiers S, Price TJ

    Pain reports 2021; (6(1)):e885 doi:10.1097/PR9.0000000000000885.

    PMID: 33458558
  57. 57

    Intraepidermal Nerve Fiber Density as Measured by Skin Punch Biopsy as a Marker for Small Fiber Neuropathy: Application in Patients with Fibromyalgia.

    Kelley MA, Hackshaw KV

    Diagnostics (Basel, Switzerland) 2021; (11(3)) doi:10.3390/diagnostics11030536.

    PMID: 33802768
  58. 58

    Large Mitochondrial DNA Deletions in HIV Sensory Neuropathy.

    Roda RH, Bargiela D, Chen W, et al.

    Neurology 2021; (97(2)):e156-e165 doi:10.1212/WNL.0000000000012142.

    PMID: 33947785
  59. 59

    PEER systematic review of randomized controlled trials: Management of chronic neuropathic pain in primary care.

    Falk J, Thomas B, Kirkwood J, et al.

    Canadian family physician Medecin de famille canadien 2021; (67(5)):e130-e140 doi:10.46747/cfp.6705e130.

    PMID: 33980642
  60. 60

    Prevention of HIV-1 TAT Protein-Induced Peripheral Neuropathy and Mitochondrial Disruption by the Antimuscarinic Pirenzepine.

    Han MM, Frizzi KE, Ellis RJ, et al.

    Frontiers in neurology 2021; (12()):663373 doi:10.3389/fneur.2021.663373.

    PMID: 34211430
  61. 61

    Analgesic Effect of Electroacupuncture on Postherpetic Neuralgia: A Trial Protocol for a Multicenter Randomized Controlled Trial.

    Liu Q, Wu X, Guo J, et al.

    Pain and therapy 2021; (10(2)):1755-1771 doi:10.1007/s40122-021-00283-8.

    PMID: 34254233
  62. 62

    Diagnosing small fiber neuropathy in clinical practice: a deep phenotyping study.

    Egenolf N, Zu Altenschildesche CM, Kreß L, et al.

    Therapeutic advances in neurological disorders 2021; (14()):17562864211004318 doi:10.1177/17562864211004318.

    PMID: 34335876
  63. 63

    Small fiber neuropathy associated with SARS-CoV-2 infection.

    Abrams RMC, Simpson DM, Navis A, et al.

    Muscle & nerve 2022; (65(4)):440-443 doi:10.1002/mus.27458.

    PMID: 34766365
  64. 64

    Change in Cav3.2 T-Type Calcium Channel Induced by Varicella-Zoster Virus Participates in the Maintenance of Herpetic Neuralgia.

    Li R, Ou M, Yang S, et al.

    Frontiers in neurology 2021; (12()):741054 doi:10.3389/fneur.2021.741054.

    PMID: 34917013
  65. 65

    Neuropathogenicity of non-viable Borrelia burgdorferi ex vivo.

    Parthasarathy G, Gadila SKG

    Scientific reports 2022; (12(1)):688 doi:10.1038/s41598-021-03837-0.

    PMID: 35027599
  66. 66

    Review of techniques useful for the assessment of sensory small fiber neuropathies: Report from an IFCN expert group.

    Verdugo RJ, Matamala JM, Inui K, et al.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2022; (136()):13-38 doi:10.1016/j.clinph.2022.01.002.

    PMID: 35131635
  67. 67

    Short-Term Spinal Cord Stimulation or Pulsed Radiofrequency for Elderly Patients with Postherpetic Neuralgia: A Prospective Randomized Controlled Trial.

    Sheng L, Liu Z, Zhou W, et al.

    Neural plasticity 2022; (2022()):7055697 doi:10.1155/2022/7055697.

    PMID: 35529453
  68. 68

    Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia.

    Peng Q, Guo X, Luo Y, et al.

    Frontiers in immunology 2022; (13()):887892 doi:10.3389/fimmu.2022.887892.

    PMID: 35720399
  69. 69

    Lyme neuroborreliosis: known knowns, known unknowns.

    Halperin JJ, Eikeland R, Branda JA, Dersch R

    Brain : a journal of neurology 2022; (145(8)):2635-2647 doi:10.1093/brain/awac206.

    PMID: 35848861
  70. 70

    COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis.

    Williams LD, Zis P

    Journal of clinical medicine 2023; (12(4)) doi:10.3390/jcm12041672.

    PMID: 36836207
  71. 71

    The Effectiveness of Various Types of Electrical Stimulation of the Spinal Cord for Chronic Pain in Patients with Postherpetic Neuralgia: A Literature Review.

    Isagulyan E, Tkachenko V, Semenov D, et al.

    Pain research & management 2023; (2023()):6015680 doi:10.1155/2023/6015680.

    PMID: 37007861
  72. 72

    Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia.

    Wang A, Li H, Xie Z, et al.

    Dermatology and therapy 2023; (13(7)):1477-1487 doi:10.1007/s13555-023-00938-8.

    PMID: 37268784
  73. 73

    Treatment of postherpetic neuralgia by bone marrow aspirate injection: A case report.

    Honda Pazili T

    World journal of clinical cases 2023; (11(15)):3619-3624 doi:10.12998/wjcc.v11.i15.3619.

    PMID: 37383904
  74. 74

    Therapeutic Strategies for Postherpetic Neuralgia: Mechanisms, Treatments, and Perspectives.

    Tang J, Zhang Y, Liu C, et al.

    Current pain and headache reports 2023; (27(9)):307-319 doi:10.1007/s11916-023-01146-x.

    PMID: 37493871
  75. 75

    European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barré syndrome.

    van Doorn PA, Van den Bergh PYK, Hadden RDM, et al.

    European journal of neurology 2023; (30(12)):3646-3674 doi:10.1111/ene.16073.

    PMID: 37814552
  76. 76

    Predictors of respiratory failure in Guillain-Barré syndrome: a 22 year cohort study from a single Italian centre.

    Galassi G, Mazzoli M, Ariatti A, et al.

    European journal of neurology 2024; (31(1)):e16090 doi:10.1111/ene.16090.

    PMID: 37823704
  77. 77

    High risk and low prevalence diseases: Guillain-Barré syndrome.

    Madden J, Spadaro A, Koyfman A, Long B

    The American journal of emergency medicine 2024; (75()):90-97 doi:10.1016/j.ajem.2023.10.036.

    PMID: 37925758
  78. 78

    Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: A systematic review and meta-analysis.

    Hoshijima H, Mihara T, Seki H, et al.

    PloS one 2023; (18(11)):e0250909 doi:10.1371/journal.pone.0250909.

    PMID: 38019841
  79. 79

    Cutaneous nerve biopsy in patients with symptoms of small fiber neuropathy: a retrospective study.

    Løseth S, Nebuchennykh M, Brokstad RT, et al.

    Scandinavian journal of pain 2024; (24(1)) doi:10.1515/sjpain-2023-0071.

    PMID: 38381703
  80. 80

    CDDO regulates central and peripheral sensitization to attenuate post-herpetic neuralgia by targeting TRPV1/PKC-δ/p-Akt signals.

    Lu CC, Lin CY, Lu YY, et al.

    Journal of cellular and molecular medicine 2024; (28(6)):e18131 doi:10.1111/jcmm.18131.

    PMID: 38426931
  81. 81

    Nucleoside Reverse Transcriptase Inhibitors Are the Major Class of HIV Antiretroviral Therapeutics That Induce Neuropathic Pain in Mice.

    Bush K, Wairkar Y, Tang SJ

    International journal of molecular sciences 2024; (25(16)) doi:10.3390/ijms25169059.

    PMID: 39201745
  82. 82

    8. Herpes zoster and post herpetic neuralgia.

    Adriaansen EJM, Jacobs JG, Vernooij LM, et al.

    Pain practice : the official journal of World Institute of Pain 2024; doi:10.1111/papr.13423.

    PMID: 39364882
  83. 83

    Long-Term Effects of Spinal Cord Stimulation on Pain in Postherpetic Neuralgia.

    Anisimov ED, Andrushkevich OM, Dzhafarov VM, et al.

    Stereotactic and functional neurosurgery 2025; (103(1)):35-41 doi:10.1159/000542138.

    PMID: 39571564
  84. 84

    An update on botulinum toxin treatment of painful diabetic neuropathy, post-traumatic painful neuropathy/neuralgia, post-herpetic neuralgia and occipital neuralgia.

    Jabbari B, Tohidian A

    Toxicon : official journal of the International Society on Toxinology 2025; (255()):108237 doi:10.1016/j.toxicon.2025.108237.

    PMID: 39798899
  85. 85

    SARS-CoV-2-induced sensory perturbations: A narrative review of clinical phenotypes, molecular pathologies, and possible interventions.

    Serafini RA, Frere JJ, Giosan IM, Nwaneshiudu CA

    Brain, behavior, & immunity - health 2025; (45()):100983 doi:10.1016/j.bbih.2025.100983.

    PMID: 40231214
  86. 86

    From Short-Term Relief to Long-Term Management: A Meta-Analysis of Temporary Spinal Cord Stimulation and Pulsed Radiofrequency in Postherpetic Neuralgia.

    Abbas A, Sabet H, El-Moslemani M, et al.

    Neuromodulation : journal of the International Neuromodulation Society 2025; (28(6)):923-936 doi:10.1016/j.neurom.2025.03.076.

    PMID: 40278804
  87. 87

    The Role of Cytokines in Postherpetic Neuralgia.

    Shen Y, Lin P

    Journal of integrative neuroscience 2025; (24(4)):25829 doi:10.31083/JIN25829.

    PMID: 40302252
  88. 88

    Small Fiber Neuropathy in Long COVID: A Cohort Study with Multimodal Assessment and Follow-Up.

    Drobinska N, Nehme M, Assal F, et al.

    European neurology 2025; (88(2)):52-63 doi:10.1159/000546015.

    PMID: 40460818
  89. 89

    How Well do We Evaluate Small Fiber Neuropathy?: A Survey of American Academy of Neurology Members.

    Thawani S, Chan M, Ostendorf T, et al.

    Journal of clinical neuromuscular disease 2025; (26(4)):184-195 doi:10.1097/CND.0000000000000502.

    PMID: 40512966
  90. 90

    [Pain Treatment for Herpes zoster].

    Gaik C, Volberg C

    Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 2025; (60(6)):371-375 doi:10.1055/a-2281-1256.

    PMID: 40513584
  91. 91

    Small Fiber Neuropathy in Sarcoidosis.

    Voortman M, Raasing L, Burggraaff J, et al.

    Seminars in respiratory and critical care medicine 2025; (46(6)):557-563 doi:10.1055/a-2716-1691.

    PMID: 41218636
  92. 92

    Diagnostic and Screening Laboratory Tests in the Assessment of Patients With Small Fiber Neuropathy: An Evidence-Based Review-Report of the American Association of Neuromuscular and Electrodiagnostic Medicine Small Fiber Neuropathy Task Force.

    Katzberg HD, So Y, Brannagan T, et al.

    Muscle & nerve 2026; (73(6)):952-960 doi:10.1002/mus.70119.

    PMID: 41670166
  93. 93

    Spinal Cord Stimulation and DREZ Lesioning for Refractory Postherpetic Neuralgia: An Exploratory Case Series.

    Jin W, Yang D, Li J, et al.

    Journal of pain research 2026; (19()):583921 doi:10.2147/JPR.S583921.

    PMID: 42046795
  94. 94

    Efficacy and safety of gabapentinoid combination therapy versus monotherapy for the treatment of neuropathic pain.

    Li D, He Y, Fan Z, et al.

    Frontiers in physiology 2026; (17()):1802999 doi:10.3389/fphys.2026.1802999.

    PMID: 42051748
  95. 95

    Low-Level Light Therapy in Postherpetic Neuralgia: A Review of Mechanistic Insights and Clinical Implications.

    Ma YC, Chiang YC, Yu S

    Cellular and molecular neurobiology 2026; (46(1)).

    PMID: 42250031
  96. 96

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    De la Torre Canales G, Dureisseix MA, Dos Santos TG, et al.

    Drugs 2026; (86(8)):1339-1364 doi:10.1007/s40265-026-02352-8.

    PMID: 42384353
  97. 97

    Focusing on inflammation-driven pyroptosis in postherpetic neuralgia: from molecular mechanisms to therapeutic strategies.

    Zhang Y, Li X, Yin Q, et al.

    Frontiers in immunology 2026; (17()):1883546 doi:10.3389/fimmu.2026.1883546.

    PMID: 42459688
  98. 98

    Immunoinflammatory mechanisms and emerging therapies for postherpetic neuralgia.

    He S, Deng D, Luo WF

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(9)).

    PMID: 42658336